A High Dose of Complexity: Chemical Development of an Anti-Cancer Drug
Veranstaltungen
15:00 – 16:00
Liebig-Vereinigung für Organische Chemie
Dies ist ein Online Event
Jörg Gries
Bayer AG
In this case study, the development of a new active pharmaceutical ingredient for cancer treatment up to a mature clinical stage is explored. This interdisciplinary endeavor will be presented from a process chemist's perspective, emphasizing innovative synthesis strategies, overcoming scale-up challenges, and ensuring timely delivery of high-quality drug substances to safeguard clinical supply. Attendees will gain valuable insights into the complexities of drug development and the collaborative efforts crucial for success in the pharmaceutical industry
Kontaktperson
Dr. Finn Burg
Zu Ihrem Kalender hinzufügen
Interessen
Veranstaltungsdetails
15:00 – 16:00
Liebig-Vereinigung für Organische Chemie
Dies ist ein Online Event
Jörg Gries
Bayer AG
Kontaktperson
Dr. Finn Burg
Zu Ihrem Kalender hinzufügen
